Nye incitamentsprogr
Nye incitamentsprogrammer for medlemmer af koncernledelsen og den øvrige ledelse i Bavarian Nordic
April 01, 2022 04:53 ET | Bavarian Nordic A/S
  KØBENHAVN, Danmark, 1. april 2022 – I overensstemmelse med selskabets vederlagspolitik har bestyrelsen i Bavarian Nordic A/S i dag besluttet at etablere nye incitamentsprogrammer for medlemmer af...
New Incentive Progra
New Incentive Programs Established for Members of Executive and Other Management in Bavarian Nordic
April 01, 2022 04:53 ET | Bavarian Nordic A/S
  COPENHAGEN, Denmark, April 1, 2022 – In accordance with the Company’s remuneration policy, the Board of Directors of Bavarian Nordic A/S has today decided to establish new incentive programs for...
Bavarian Nordic indg
Bavarian Nordic indgår licens- og produktionsaftale med Nuance Pharma om udvikling og kommercialisering af vaccine til voksne mod respiratorisk syncytialvirus (RSV) i Kina og udvalgte asiatiske lande
March 21, 2022 02:26 ET | Bavarian Nordic A/S
Bavarian Nordic kan modtage op til USD 225 mio. i forud- og milepælsbetalinger samt stigende, tocifrede royaltybetalingerNuance Pharma opnår rettigheder til kommercialisering af MVA-BN® RSV i Kina,...
Bavarian Nordic Anno
Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets
March 21, 2022 02:26 ET | Bavarian Nordic A/S
Bavarian Nordic to receive up to USD 225 million in upfront and milestone payments in addition to tiered, double-digit royaltiesNuance Pharma obtains rights to commercialize MVA-BN® RSV in Chinese...
Indberetning af lede
Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer
March 21, 2022 02:00 ET | Bavarian Nordic A/S
KØBENHAVN, Danmark, 21. marts 2022 – Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selska bets aktie/tilknyttede værdipapirer, foretaget af ledende...
Report of transactio
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
March 21, 2022 02:00 ET | Bavarian Nordic A/S
COPENHAGEN, Denmark, March 21, 2022 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding...
Bavarian Nordic A/S
Bavarian Nordic A/S - Vedtægter
March 18, 2022 06:18 ET | Bavarian Nordic A/S
Opdaterede vedtægter for Bavarian Nordic A/S. Vedhæftet fil Bavarian Nordic - Vedtægter ...
Bavarian Nordic A/S
Bavarian Nordic A/S - Articles of Association
March 18, 2022 06:18 ET | Bavarian Nordic A/S
Updated Articles of Association for Bavarian Nordic A/S. Attachment Bavarian Nordic - Articles of Association ...
Kapitalforhøjelse i
Kapitalforhøjelse i Bavarian Nordic A/S som følge af medarbejderes udnyttelse af tegningsoptioner
March 18, 2022 05:33 ET | Bavarian Nordic A/S
KØBENHAVN, Danmark, 18. marts 2022 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har forhøjet sin aktiekapital med nominelt DKK 45.420 som følge af medarbejderes udnyttelse af...
Capital Increase in
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
March 18, 2022 05:33 ET | Bavarian Nordic A/S
COPENHAGEN, Denmark, March 18, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 45,420 as a consequence of employees’...